Eric Glenn – Synergy Worldwide

This is a study that is being done with Washington State University in collaboration with Dr. Rainer Boger that is comparing Pro-Argi9 to placebo in a 12 week double-blind trial. The study will compare baseline measures of Blood Pressure, CASP, ADMA and LpPlac2 (a vascular specific inflammatory marker) to repeated endpoint measures. Dr. Kathy Beerman (a nutrition professor from WSU) and Gretchen Millard (Registered Dietitian) are co-primary investigators. We have 19 hypertensive men currently enrolled and are recruiting until we reach our target of 60 participants. This is an exciting project and we are so grateful for the support we have received so far. Our first group should be finishing and tranferring to our open label extension by October. We should have more to share in the coming months.

LISTEN TO THESE WEBINARS NOW! Click here www.Heart2HeartSymposium.com then scroll down to the bottom of the page.

These Webinars are a great tool to share with others about amazing products for heart health and the science and studies behind them. Dr. Nick Martinuik is hosting these Thursday evening webinar events and the recordings are now available on our Heart 2 Heart Symposium website. There is so much great information in these sessions that many of you have asked to have them available to share with others so here they are. Let us know what you think, please?

Dan Hammer does a really tremendous job of explaining ProArgi9 Plus. There is a phone number, website and email at the end you should be aware of.

Researchers at the University of Michigan Comprehensive Cancer Center report in the February 15, 2011 issue of the journal Clinical Cancer Research that an enzyme elevated in lung cancer that reduces the active form of vitamin D is associated with more aggressive tumors and worse survival. The finding could aid the development of an agent to protect against the return of the disease following surgery.

Recent research suggests a preventive role for vitamin D against lung cancer as well as a benefit for the vitamin in lung cancer survival. For the current study, University of Michigan School of Medicine associate professor of internal medicine Nithya Ramnath, MD and colleagues evaluated tumor samples from 86 patients with lung adenocarcinoma to determine the level of CYP24A1, which encodes an enzyme that is overexpressed in many cancers. This enzyme breaks down calcitriol (1-alpha,25-dihydroxyvitamin D3), which has an antiproliferative effect in lung adenocarcinoma and other malignancies. The team found that CYP24A1 expression was 8 to 50 times higher in cancerous compared to healthy lung tissue. Patients with higher levels of CYP24A1, who comprised approximately one-third of the subjects, had an increased likeliness of aggressive tumors and a 42 percent chance of survival after five years compared with an 81 percent chance for those with low CYP24A1. In experiments with lung cancer cell lines, cells that expressed high levels of CYP24A1 were demonstrated to be more resistant to treatment with calcitriol compared to those with low CYP24A1.

“Half of lung cancers will recur after surgery, so it’s important to find a way to prevent or delay this recurrence,” Dr Ramnath remarked. “A natural compound like vitamin D is attractive because it has few side effects, but it’s even better if we can determine exactly who would benefit from receiving vitamin D.”

Scientists are now attempting to identify compounds that block CYP24A1, which would increase vitamin D’s anticancer potential, and could be combined with vitamin D treatment.

Angelo Cici discusses his experience taking ProArgi9 Plus and his personal story and journey on his road back to living an active full life. We thank him for his honest approach and sincere desire to help everyone he meets avoid disease and heart challenges.

By MARILYNN MARCHIONE

The Associated Press

(original article at http://www.sltrib.com/sltrib/world/51223403-68/stroke-among-age-strokes.html.csp)

Los Angeles • Strokes are rising dramatically among young and middle-aged Americans while dropping in older people, a sign that the obesity epidemic may be starting to shift the age burden of the disease.

The numbers, reported Wednesday at an American Stroke Association conference, come from the first large nationwide study of stroke hospitalizations by age. Government researchers compared hospitalizations in 1994 and 1995 with ones in 2006 and 2007.

The sharpest increase — 51 percent — was among men 15 through 34. Strokes rose among women in this age group, too, but not as fast — 17 percent.

“It’s definitely alarming,” said Ralph Sacco, American Heart Association president and a neurologist at the University of Miami. “We have worried for a while that the increased prevalence of obesity in children and young adults may take its toll in cardiovascular disease and stroke,” and that appears to be happening, he said.

Stroke still takes its highest toll on older people. For those over 65, there were nearly 300 stroke cases among 10,000 hospitalizations in the more recent period studied. For males 15 to 34, there were about 15 stroke cases per 10,000, and for girls and women in that age group there were about 4 per 10,000.

Several small studies had recently suggested an ominous rise among the young and among middle-aged women.

New!!! NOW YOU CAN LISTEN to this recorded call ON THE PHONE! Simply dial the phone number
(512) 827-0080 and then input the PIN 55555# (five 5’s and a #).

This is the same call from 1-26-11 that was posted before only this version is without the introduction about the Heart Symposium. In this audio Dan Austin, the RN that administrated the heart study and a patient, Angelo Cici, explain the science and experience of the study.

You can also copy and paste either link below to email this recording:

http://ericglenn.com/2011/02/high-desert-heart-institute-heart-study-with-dan-austin-and-angelo-cici

or
http://www.byoaudio.com/play/WzNDw874

or download to your device below:

You asked for it so here it is!! This is the conference call from 1-26-11 in which Bill Styles, Dan Austin and Angelo Cici participated in explaining the Heart Symposium and High Desert Heart Institute heart study. I have had more people ask for this recording than any call we have ever done. Enjoy!

Here are two links you can use to send out in emails if you need to
(simply copy and paste either link into your email):
http://ericglenn.com/2011/02/high-desert-heart-institute-and-heart-symposium-2
or
http://www.byoaudio.com/play/WqGq0PX4

Or Download the file for playing on your devices:

<=Click on the photo to the left to watch the video.

Dr. Oz and Dr. Mercola talk about a few things and finally finish up on L-Arginine. Neat experiment to give an example of hardening of the arteries.

Dr. Nick Martinuik’s father, Lorin, gives a brilliant testimonial of ProArgi9 and his heart health experience with his doctors in Canada. Listen to the end when he tells why a Dr. in Canada must be careful. Lorin is a nurse in Canada for a few decades and has been very active in the medical community. Thank you Lorin for sharing.